ABOUT BREAST CANCER TRIALS

STRATEGIC PLAN

Breast Cancer Trials is a group of world-leading breast cancer doctors and researchers based in Australia and New Zealand committed to exploring and finding better treatments for people affected by breast cancer through clinical trials research.

The Breast Cancer Trials (BCT) Strategic Plan 2019–2023 builds on the successes of our past. It provides the framework for our current national and international research program, harnessing the expertise and passion of our multidisciplinary membership and our international collaborative partners. The plan guides the organisation through a strategic approach to partnerships, resourcing and communication.

BCT has been tracking sixteen key performance indicators (KPI’s) to measure progress towards achieving the Strategic Plan. As at March 2023, 11 of those KPI’s are tracking ahead, or close to target. KPI’s are revised on an annual basis.

Pillar 1

World Class Multidisciplinary Breast Cancer Clinical Trials

  • Leading and proactively contributing to national and international breast cancer clinical trials relevant to the Australian and New Zealand population.
  • Leading a diverse clinical research portfolio covering clinically relevant and consumer-centred research questions across the breast cancer continuum.
  • Fostering a vibrant and engaged breast cancer research community with the capacity to conduct innovative breast cancer clinical trials.

Pillar 2

Sustainable Foundations for Research

  • Responsibly sourcing and being transparent about the use of funds.
  • Creating the optimal foundation for our research through the skills, capabilities and capacity of our governance and workforce.
  • Maximising the efficiency and effectiveness of clinical trial operations and organisational processes through effective use of technology.

Pillar 3

Driving Awareness and Influencing Change

  • Positioning Breast Cancer Trials as the national and international leader in breast cancer research through strategic communications and marketing of our research agenda, activities, progress and outcomes.
  • Using our voice and influence to address barriers to clinical research and strengthening the translation of our research outcomes into practice.
NEXT – BREAST CANCER TODAY